Difference between revisions of "OpenEMR Certification Stage II Meaningful Use"

From OpenEMR Project Wiki
 
(381 intermediate revisions by 3 users not shown)
Line 1: Line 1:
=Overview=
=Overview=
:This is the project page for the OpenEMR Certification Stage II Meaningful Use project, which is due before 1/1/2015. '''The goal is to have certification by 1/1/2015'''. There are 45 [[OpenEMR_Certification_Stage_II_Meaningful_Use#Certification_Criteria|Certification Criteria]], which are organized into 7 different topics ([[OpenEMR_Certification_Stage_II_Meaningful_Use#Clinical (170.314(a))|Clinical]], [[OpenEMR_Certification_Stage_II_Meaningful_Use#Care Coordination (170.314(b))|Care Coordination]], [[OpenEMR_Certification_Stage_II_Meaningful_Use#Clinical Quality Measures (170.314(c))|Clinical Quality Measures]], [[OpenEMR_Certification_Stage_II_Meaningful_Use#Privacy and Security (170.314(d))|Privacy and Security]], [[OpenEMR_Certification_Stage_II_Meaningful_Use#Patient Engagement (170.314(e))|Patient Engagement]], [[OpenEMR_Certification_Stage_II_Meaningful_Use#Public Health (170.314(f))|Public Health]], and [[OpenEMR_Certification_Stage_II_Meaningful_Use#Utilization (170.314(g))|Utilization]]).
:This is the project page for the OpenEMR Certification Stage II Meaningful Use project. '''Modular Certification was obtained on December 24, 2014 (for OpenEMR 4.2.x which was released on 12/28/14).''' '''Complete Certification was obtained on February 13, 2017 (for OpenEMR 5.0.x which was released on 2/15/17).''' There are 45 [[OpenEMR_Certification_Stage_II_Meaningful_Use#Certification_Criteria|Certification Criteria]], which are organized into 7 different topics ([[OpenEMR_Certification_Stage_II_Meaningful_Use#Clinical (170.314(a))|Clinical]], [[OpenEMR_Certification_Stage_II_Meaningful_Use#Care Coordination (170.314(b))|Care Coordination]], [[OpenEMR_Certification_Stage_II_Meaningful_Use#Clinical Quality Measures (170.314(c))|Clinical Quality Measures]], [[OpenEMR_Certification_Stage_II_Meaningful_Use#Privacy and Security (170.314(d))|Privacy and Security]], [[OpenEMR_Certification_Stage_II_Meaningful_Use#Patient Engagement (170.314(e))|Patient Engagement]], [[OpenEMR_Certification_Stage_II_Meaningful_Use#Public Health (170.314(f))|Public Health]], and [[OpenEMR_Certification_Stage_II_Meaningful_Use#Utilization (170.314(g))|Utilization]]).
:Here are some useful links:
:Here are some useful links:
:*[http://www.healthit.gov/policy-researchers-implementers/meaningful-use-stage-2-0 HealthIT.gov Stage 2 Page]
:*[http://www.healthit.gov/policy-researchers-implementers/meaningful-use-stage-2-0 HealthIT.gov Stage 2 Page]
Line 15: Line 15:


=Fund Raising=
=Fund Raising=
:This barometer will track the funds available via the [http://oemr.org/ OEMR 501c3] that are dedicated to this goal
:This barometer will track the approximate funds available via the [http://oemr.org/ OEMR 501c3] that are dedicated to this goal


{|
{|
Line 21: Line 21:
|style="color:white; background-color:blue"|Certification Test Funds
|style="color:white; background-color:blue"|Certification Test Funds
|style="color:white; background-color:green"|Development Funds
|style="color:white; background-color:green"|Development Funds
|style="color:white; background-color:orange"|Expended Funds
|}
|}


Line 27: Line 28:
{|style="border:1px solid darkgray;"
{|style="border:1px solid darkgray;"
|-
|-
|style="color:white; background-color:blue"|$1000
|style="color:white; background-color:orange"|$1000
|style="color:white; background-color:blue"|$5000
|style="color:white; background-color:orange"|$5000
|style="color:white; background-color:blue"|$10,000
|style="color:white; background-color:orange"|$10,000
|style="color:white; background-color:blue"|$15,000  
|style="color:white; background-color:orange"|$15,000  
|style="color:white; background-color:blue"|$20,000
|style="color:white; background-color:orange"|$20,000
|style="color:white; background-color:blue"|$25,000
|style="color:white; background-color:orange"|$25,000
|} GOAL ACHIEVED! --[[User:Tony McCormick|Tony McCormick]] 22:27, 29 January 2014 (UTC)
|} GOAL ACHIEVED! --[[User:Tony McCormick|Tony McCormick]] 22:27, 29 January 2014 (UTC)


'''Required to support development efforts and timely delivery (by June 1)'''
'''Required to support development efforts and timely delivery'''


{|style="border:1px solid darkgray;"
{|style="border:1px solid darkgray;"
Line 43: Line 44:
|style="color:white; background-color:green"|$10,000
|style="color:white; background-color:green"|$10,000
|style="color:white; background-color:green"|$12,500
|style="color:white; background-color:green"|$12,500
|style="color:white; background-color:gray"|$15,000
|style="color:white; background-color:green"|$15,000
|style="color:white; background-color:gray"|$20,000
|style="color:white; background-color:gray"|$20,000
|style="color:white; background-color:gray"|$25,000
|style="color:white; background-color:gray"|$25,000
Line 57: Line 58:
|style="color:white; background-color:gray"|$75,000
|style="color:white; background-color:gray"|$75,000
|}
|}
<br>
<br>
<div style="font-size:80%;border:1px solid;">
<div style="font-size:80%;border:1px solid;">
Line 63: Line 63:
:*<span style="color:white; background-color:gray">Not Funded</span> - Unfunded Goal.
:*<span style="color:white; background-color:gray">Not Funded</span> - Unfunded Goal.
:*<span style="color:white; background-color:blue">Certification Test Cost</span> - Funds available to pay for Certification Testing
:*<span style="color:white; background-color:blue">Certification Test Cost</span> - Funds available to pay for Certification Testing
:*<span style="color:white; background-color:green">Development</span> - Funds available for development work
:*<span style="color:white; background-color:green">Development</span> - Funds available for development work  
:* '''*''' notes There are funds pledged to date of $8000 and matching funds of up to 10% of the overall funding
</div>
</div>
<br>
<br>
<br>
==Fund Drive for OpenEMR MU Certification==
:'''<span style="font-size:115%"> Please continue to help OpenEMR obtain Meaningful Use Certification!!'''</span>
<br>
<center style="font-size:150%">'''[http://www.open-emr.org DONATE HERE]'''</center>
<br>
<br>
<center style="font-size:150%">'''[http://www.open-emr.org DONATE HERE]'''</center>
<br>
<br>


=Completion Barometer=
=Completion Barometer=
:*Most updated testing results and details can be found on this zipped spreadsheet file(updated 11/11/2014): [[File:2014-test-procedures_tools-11-11-2014.zip]]
:*'''Modular Certification was obtained on December 24, 2014 (for OpenEMR 4.2.x which was released on 12/28/14).'''
:*This barometer will track the progress of the Stage 2 MU project. See below [[OpenEMR_Certification_Stage_II_Meaningful_Use#Certification_Criteria|Certification Criteria]] section for criteria titles.
:*'''Complete Certification was obtained on February 13, 2017 (for OpenEMR 5.0.x which was released on 2/15/17).'''
:*Was submitted for "Certification Body Review" on 12/14/2016. The "Certification Body" requested 5 items to be fixed on 1/18/2017, which were all passed by 2/8/17. The application was then resubmitted for  "Certification Body Review" on 2/10/2017. Complete MU2 certification was officially certified on 2/13/2017!
:*This barometer is tracking the progress of the Stage 2 MU project. See below [[OpenEMR_Certification_Stage_II_Meaningful_Use#Certification_Criteria|Certification Criteria]] section for criteria titles.
{|style="border:1px solid darkgray;"
{|style="border:1px solid darkgray;"
|-
|-
|style="color:white; background-color:purple"|a1*
|style="border:2px solid darkgrey; padding:2px; color:white; background-color:purple"|a1
|style="color:white; background-color:green"|a2
|style="border:2px solid darkgrey; padding:2px; color:white; background-color:purple"|a2
|style="color:white; background-color:purple"|a3
|style="border:2px solid darkgrey; padding:2px; color:white; background-color:purple"|a3
|style="color:white; background-color:purple"|a4
|style="border:2px solid darkgrey; padding:2px; color:white; background-color:purple"|a4
|style="color:white; background-color:purple"|a5
|style="border:2px solid darkgrey; padding:2px; color:white; background-color:purple"|a5
|style="color:white; background-color:purple"|a6*
|style="border:2px solid darkgrey; padding:2px; color:white; background-color:purple"|a6
|style="color:white; background-color:purple"|a7*
|style="border:2px solid darkgrey; padding:2px; color:white; background-color:purple"|a7
|style="color:white; background-color:green"|a8
|style="border:2px solid darkgrey; padding:2px; color:white; background-color:purple"|a8
|style="color:white; background-color:purple"|a9
|style="border:2px solid darkgrey; padding:2px; color:white; background-color:purple"|a9
|style="color:white; background-color:green"|a10
|style="border:2px solid darkgrey; padding:2px; color:white; background-color:purple"|a10
|style="color:white; background-color:purple"|a11
|style="border:2px solid darkgrey; padding:2px; color:white; background-color:purple"|a11
|style="color:white; background-color:purple"|a12
|style="border:2px solid darkgrey; padding:2px; color:white; background-color:purple"|a12
|style="color:white; background-color:purple"|a13
|style="border:2px solid darkgrey; padding:2px; color:white; background-color:purple"|a13
|style="color:white; background-color:red"|a14
|style="border:2px solid darkgrey; padding:2px; color:white; background-color:purple"|a14
|style="color:white; background-color:purple"|a15
|style="border:2px solid darkgrey; padding:2px; color:white; background-color:purple"|a15
|style="color:white; background-color:green"|b1
|style="border:2px solid darkgrey; padding:2px; color:white; background-color:purple"|b1
|style="color:white; background-color:green"|b2
|style="border:2px solid darkgrey; padding:2px; color:white; background-color:purple"|b2
|style="color:white; background-color:green"|b3
|style="border:2px solid darkgrey; padding:2px; color:white; background-color:purple"|b3
|style="color:white; background-color:green"|b4
|style="border:2px solid darkgrey; padding:2px; color:white; background-color:purple"|b4
|style="color:white; background-color:green"|b5
|style="border:2px solid darkgrey; padding:2px; color:white; background-color:purple"|b5
|style="color:white; background-color:green"|b7
|style="border:2px solid darkgrey; padding:2px; color:white; background-color:purple"|b7
|style="color:white; background-color:red"|c1
|style="border:2px solid darkgrey; padding:2px; color:white; background-color:purple"|c1
|style="color:white; background-color:red"|c2
|style="border:2px solid darkgrey; padding:2px; color:white; background-color:purple"|c2
|style="color:white; background-color:red"|c3
|style="border:2px solid darkgrey; padding:2px; color:white; background-color:purple"|c3
|style="color:white; background-color:purple"|d1*
|style="border:2px solid darkgrey; padding:2px; color:white; background-color:purple"|d1
|style="color:white; background-color:purple"|d2
|style="border:2px solid darkgrey; padding:2px; color:white; background-color:purple"|d2
|style="color:white; background-color:purple"|d3
|style="border:2px solid darkgrey; padding:2px; color:white; background-color:purple"|d3
|style="color:white; background-color:purple"|d4
|style="border:2px solid darkgrey; padding:2px; color:white; background-color:purple"|d4
|style="color:white; background-color:purple"|d5
|style="border:2px solid darkgrey; padding:2px; color:white; background-color:purple"|d5
|style="color:white; background-color:purple"|d6*
|style="border:2px solid darkgrey; padding:2px; color:white; background-color:purple"|d6
|style="color:white; background-color:purple"|d7
|style="border:2px solid darkgrey; padding:2px; color:white; background-color:purple"|d7
|style="color:white; background-color:purple"|d8*
|style="border:2px solid darkgrey; padding:2px; color:white; background-color:purple"|d8
|style="color:white; background-color:purple"|d9*
|style="border:2px solid darkgrey; padding:2px; color:white; background-color:purple"|d9
|style="color:white; background-color:red"|e1
|style="border:2px solid darkgrey; padding:2px; color:white; background-color:purple"|e1
|style="color:white; background-color:red"|e2
|style="border:2px solid darkgrey; padding:2px; color:white; background-color:purple"|e2
|style="color:white; background-color:purple"|e3
|style="border:2px solid darkgrey; padding:2px; color:white; background-color:purple"|e3
|style="color:white; background-color:purple"|f1*
|style="border:2px solid darkgrey; padding:2px; color:white; background-color:purple"|f1
|style="color:white; background-color:red"|f2
|style="border:2px solid darkgrey; padding:2px; color:white; background-color:purple"|f2
|style="color:white; background-color:red"|f3
|style="border:2px solid darkgrey; padding:2px; color:white; background-color:purple"|f3
|style="color:white; background-color:red"|g1
|style="border:2px solid darkgrey; padding:2px; color:white; background-color:purple"|g2
|style="color:white; background-color:red"|g2
|style="border:2px solid darkgrey; padding:2px; color:white; background-color:purple"|g3
|style="color:white; background-color:purple"|g3
|style="border:2px solid darkgrey; padding:2px; color:white; background-color:purple"|g4
|style="color:white; background-color:purple"|g4
|}
{|
|style="color:white; background-color:red"|Not Ready
|style="color:white; background-color:green"|Ready
|style="color:white; background-color:plum"|Certified
|style="color:white; background-color:purple"|Certified and in Official Codebase
|}
|}
<br>
<br>
Line 129: Line 131:
:*<span style="color:white; background-color:red">Not Ready</span> - Not ready for certification testing.
:*<span style="color:white; background-color:red">Not Ready</span> - Not ready for certification testing.
:*<span style="color:white; background-color:green">Ready</span> - Ready for certification testing.
:*<span style="color:white; background-color:green">Ready</span> - Ready for certification testing.
:*<span style="color:white; background-color:plum">Certification Pass</span> - Passed certification but not yet in official codebase.
:*<span style="color:white; background-color:orange">Failed Test</span> - Issues found during certification testing.
:*<span style="color:white; background-color:plum">Certification Pass</span> - Passed certification, but not yet in official codebase.
:*<span style="color:white; background-color:purple">Certification Pass</span> - Passed certification and in official codebase.
:*<span style="color:white; background-color:purple">Certification Pass</span> - Passed certification and in official codebase.
:* '''*''' notes Gap Eligible Criteria (Criteria categorized as "Unchanged" between 2011 and 2014 edition)
:*<span style="color:white; background-color:black">Certification Body Review Issues</span> - Issues requested by Certification Body to address.
</div>
</div>
<br>
<br>
Line 140: Line 143:
:*Owner - This is the "current" person/group(s) that are working on this criteria and can be found in parenthesis next to the item.
:*Owner - This is the "current" person/group(s) that are working on this criteria and can be found in parenthesis next to the item.
==Clinical (170.314(a))==
==Clinical (170.314(a))==
:'''a1.''' [[Computerized provider order entry (MU2)|Computerized provider order entry]] (<span style="color:white; background-color:green">Finalized</span>)
:'''a1.''' [[Computerized provider order entry (MU2)|Computerized provider order entry]] (<span style="color:white; background-color:green">Finalized - Visolve</span>)
:'''a2.''' [[Drug-drug, drug-allergy interaction checks (MU2)|Drug-drug, drug-allergy interaction checks]] (<span style="color:green;">owner is MI2/ZHH Via NewCrop</span>)
:'''a2.''' [[Drug-drug, drug-allergy interaction checks (MU2)|Drug-drug, drug-allergy interaction checks]] (<span style="color:white; background-color:green">Finalized - MI-Squared/NewCrop</span>)
:'''a3.''' [[Demographics (MU2)|Demographics]] (<span style="color:white; background-color:green">Finalized - Jan Jajalla</span>)
:'''a3.''' [[Demographics (MU2)|Demographics]] (<span style="color:white; background-color:green">Finalized - Jan Jajalla and Visolve</span>)
:'''a4.''' [[Vital signs, body mass index, and growth charts (MU2)|Vital signs, body mass index, and growth charts]] (<span style="color:white; background-color:green">Finalized - Jan Jajalla</span>)
:'''a4.''' [[Vital signs, body mass index, and growth charts (MU2)|Vital signs, body mass index, and growth charts]] (<span style="color:white; background-color:green">Finalized - Jan Jajalla</span>)
:'''a5.''' [[Problem list (MU2)|Problem list]] (<span style="color:white; background-color:green">Finalized - ZH Healthcare</span>)
:'''a5.''' [[Problem list (MU2)|Problem list]] (<span style="color:white; background-color:green">Finalized - ZH Healthcare and Visolve</span>)
:'''a6.''' [[Medication list (MU2)|Medication list]] (<span style="color:white; background-color:green">Finalized</span>)
:'''a6.''' [[Medication list (MU2)|Medication list]] (<span style="color:white; background-color:green">Finalized</span>)
:'''a7.''' [[Medication allergy list (MU2)|Medication allergy list]] (<span style="color:white; background-color:green">Finalized</span>)
:'''a7.''' [[Medication allergy list (MU2)|Medication allergy list]] (<span style="color:white; background-color:green">Finalized</span>)
:'''a8.''' [[Clinical decision support (MU2)|Clinical decision support]] (<span style="color:green;">owner is ZH Healthcare/EnSoftek</span>)
:'''a8.''' [[Clinical decision support (MU2)|Clinical decision support]] (<span style="color:white; background-color:green">Finalized - EnSoftek and Visolve and MI-Squared and Brady Miller</span>)
:'''a9.''' [[Electronic notes (MU2)|Electronic notes]] (<span style="color:white; background-color:green">Finalized - ZH Healthcare</span>)
:'''a9.''' [[Electronic notes (MU2)|Electronic notes]] (<span style="color:white; background-color:green">Finalized - ZH Healthcare</span>)
:'''a10.''' [[Drug-formulary checks (MU2)|Drug-formulary checks]] (<span style="color:green;">owner is MI2/ZHH Via NewCrop</span>)
:'''a10.''' [[Drug-formulary checks (MU2)|Drug-formulary checks]] (<span style="color:white; background-color:green">Finalized - MI-Squared/ZH Healthcare Via NewCrop</span>)
:'''a11.''' [[Smoking status (MU2)|Smoking status]] (<span style="color:white; background-color:green">Finalized - Brady Miller and Ensoftek</span>)
:'''a11.''' [[Smoking status (MU2)|Smoking status]] (<span style="color:white; background-color:green">Finalized - Brady Miller and Ensoftek</span>)
:'''a12.''' [[Image results (MU2)|Image results]] (<span style="color:white; background-color:green">Finalized - Ensoftek</span>)
:'''a12.''' [[Image results (MU2)|Image results]] <span style="color:white; background-color:green">Finalized - Ensoftek and Visolve</span>)
:'''a13.''' [[Family health history (MU2)|Family health history]] (<span style="color:white; background-color:green">Finalized - Ensoftek</span>)
:'''a13.''' [[Family health history (MU2)|Family health history]] (<span style="color:white; background-color:green">Finalized - Ensoftek</span>)
:'''a14.''' [[Patient list creation (MU2)|Patient list creation]] (<span style="color:green;">owner is EnSoftek</span>)
:'''a14.''' [[Patient list creation (MU2)|Patient list creation]] (<span style="color:white; background-color:green">Finalized - Ensoftek and Visolve</span>)
:'''a15.''' [[Patient-specific education resources (MU2)|Patient-specific education resources]] (<span style="color:white; background-color:green">Finalized - Sunset Systems</span>)
:'''a15.''' [[Patient-specific education resources (MU2)|Patient-specific education resources]] (<span style="color:white; background-color:green">Finalized - Sunset Systems</span>)


==Care Coordination (170.314(b))==
==Care Coordination (170.314(b))==
:'''b1.''' [[Transitions of care – receive, display, and incorporate transition of care/referral summaries (MU2)|Transitions of care – receive, display, and incorporate transition of care/referral summaries]] (<span style="color:green;">owner is ZH Healthcare</span>)
:'''b1.''' [[Transitions of care – receive, display, and incorporate transition of care/referral summaries (MU2)|Transitions of care – receive, display, and incorporate transition of care/referral summaries]] (<span style="color:white; background-color:green">Finalized - ZH Healthcare and EMR Direct</span>)
:'''b2.''' [[Transitions of care – create and transmit transition of care/referral summaries (MU2)|Transitions of care – create and transmit transition of care/referral summaries]] (<span style="color:green;">owner is ZH Healthcare</span>)
:'''b2.''' [[Transitions of care – create and transmit transition of care/referral summaries (MU2)|Transitions of care – create and transmit transition of care/referral summaries]] (<span style="color:white; background-color:green">Finalized - ZH Healthcare and EMR Direct</span>)
:'''b3.''' [[Electronic prescribing (MU2)|Electronic prescribing]] (<span style="color:green;">owner is ZH Healthcare/Ensoftek</span>)
:'''b3.''' [[Electronic prescribing (MU2)|Electronic prescribing]] (<span style="color:white; background-color:green">Finalized - MI-Squared/Ensoftek</span>)
:'''b4.''' [[Clinical information reconciliation (MU2)|Clinical information reconciliation]] (<span style="color:green;">owner is ZH Healthcare/Ensoftek</span>)
:'''b4.''' [[Clinical information reconciliation (MU2)|Clinical information reconciliation]] (<span style="color:white; background-color:green">Finalized - ZH Healthcare</span>)
:'''b5.''' [[Incorporate lab tests and values/results (MU2)|Incorporate lab tests and values/results]] (<span style="color:green;">owner is OEMR (using code already in 4.1.3)</span>)
:'''b5.''' [[Incorporate lab tests and values/results (MU2)|Incorporate lab tests and values/results]] (<span style="color:white; background-color:green">Finalized - Sunset Systems and MI-Squared</span>)
:'''b7.''' [[Data portability (MU2)|Data portability]] (<span style="color:green;">owner is ZH Healthcare</span>)
:'''b7.''' [[Data portability (MU2)|Data portability]] (<span style="color:white; background-color:green">Finalized - ZH Healthcare</span>)


==Clinical Quality Measures (170.314(c))==
==Clinical Quality Measures (170.314(c))==
:'''c1.''' [[Clinical quality measures - capture and export (MU2)|Clinical quality measures - capture and export]] (<span style="color:green;">owner is OEMR</span>)
:'''c1.''' [[Clinical quality measures - capture and export (MU2)|Clinical quality measures - capture and export]] (<span style="color:white; background-color:green">Finalized - Ensoftek and Visolve</span>)
:'''c2.''' [[Clinical quality measures - import and calculate (MU2)|Clinical quality measures - import and calculate]] (<span style="color:green;">owner is OEMR</span>)
:'''c2.''' [[Clinical quality measures - import and calculate (MU2)|Clinical quality measures - import and calculate]] (<span style="color:white; background-color:green">Finalized - Ensoftek and Visolve</span>)
:'''c3.''' [[Clinical quality measures - electronic submission (MU2)|Clinical quality measures - electronic submission]] (<span style="color:green;">owner is OEMR</span>)
:'''c3.''' [[Clinical quality measures - electronic submission (MU2)|Clinical quality measures - electronic submission]] (<span style="color:white; background-color:green">Finalized - Ensoftek and Visolve</span>)


==Privacy and Security (170.314(d))==
==Privacy and Security (170.314(d))==
:'''d1.''' [[Authentication, access control, and authorization (MU2)|Authentication, access control, and authorization]] (<span style="color:white; background-color:green">Finalized</span>)
:'''d1.''' [[Authentication, access control, and authorization (MU2)|Authentication, access control, and authorization]] (<span style="color:white; background-color:green">Finalized</span>)
:'''d2.''' [[Auditable events and tamper-resistance (MU2)|Auditable events and tamper-resistance]] (<span style="color:white; background-color:green">Finalized - Ensoftek</span>)
:'''d2.''' [[Auditable events and tamper-resistance (MU2)|Auditable events and tamper-resistance]] (<span style="color:white; background-color:green">Finalized - Ensoftek, MI-Squared, Sunset Systems, and Visolve</span>)
:'''d3.''' [[Audit report(s) (MU2)|Audit report(s)]] (<span style="color:white; background-color:green">Finalized - Ensoftek</span>)
:'''d3.''' [[Audit report(s) (MU2)|Audit report(s)]] (<span style="color:white; background-color:green">Finalized - Ensoftek and Visolve</span>)
:'''d4.''' [[Amendments (MU2)|Amendments]] (<span style="color:white; background-color:green">Finalized - Ensoftek</span>)
:'''d4.''' [[Amendments (MU2)|Amendments]] (<span style="color:white; background-color:green">Finalized - Ensoftek</span>)
:'''d5.''' [[Automatic log-off (MU2)|Automatic log-off]] (<span style="color:white; background-color:green">Finalized</span>)
:'''d5.''' [[Automatic log-off (MU2)|Automatic log-off]] (<span style="color:white; background-color:green">Finalized</span>)
:'''d6.''' [[Emergency access (MU2)|Emergency access]] (<span style="color:white; background-color:green">Finalized</span>)
:'''d6.''' [[Emergency access (MU2)|Emergency access]] (<span style="color:white; background-color:green">Finalized</span>)
:'''d7.''' [[End-user device encryption (MU2)|End-user device encryption]] (<span style="color:white; background-color:green">Finalized</span>)
:'''d7.''' [[End-user device encryption (MU2)|End-user device encryption]] (<span style="color:white; background-color:green">Finalized</span>)
:'''d8.''' [[Integrity (MU2)|Integrity]] (<span style="color:white; background-color:green">Finalized</span>)
:'''d8.''' [[Integrity (MU2)|Integrity]] (<span style="color:white; background-color:green">Finalized - Visolve</span>)
:'''d9.''' [[Accounting of disclosures (MU2))|Accounting of disclosures]] (<span style="color:white; background-color:green">Finalized - Ensoftek</span>)
:'''d9.''' [[Accounting of disclosures (MU2))|Accounting of disclosures]] (<span style="color:white; background-color:green">Finalized - Ensoftek</span>)


==Patient Engagement (170.314(e))==
==Patient Engagement (170.314(e))==
:'''e1.''' [[View, download, and transmit to 3rd party (MU2))|View, download, and transmit to 3rd party]] (<span style="color:green;">owner is ZH Healthcare</span>)
:'''e1.''' [[View, download, and transmit to 3rd party (MU2))|View, download, and transmit to 3rd party]] (<span style="color:white; background-color:green">Finalized - ZH Healthcare and EMR Direct</span>)
:'''e2.''' [[Clinical summaries (MU2))|Clinical summaries]] (<span style="color:green;">owner is Ensoftek</span>)
:'''e2.''' [[Clinical summaries (MU2))|Clinical summaries]] (<span style="color:white; background-color:green">Finalized - ZH Healthcare</span>)
:'''e3.''' [[Secure messaging (MU2))|Secure messaging]] (<span style="color:white; background-color:green">Finalized - ZH Healthcare</span>)
:'''e3.''' [[Secure messaging (MU2))|Secure messaging]] (<span style="color:white; background-color:green">Finalized - ZH Healthcare</span>)


==Public Health (170.314(f))==
==Public Health (170.314(f))==
:'''f1.''' [[Immunization information (MU2))|Immunization information]] (<span style="color:white; background-color:green">Finalized - Jan Jajalla</span>)
:'''f1.''' [[Immunization information (MU2))|Immunization information]] (<span style="color:white; background-color:green">Finalized - Jan Jajalla</span>)
:'''f2.''' [[Transmission to immunization registries (MU2))|Transmission to immunization registries]] (<span style="color:green;">owner is Ensoftek</span>)
:'''f2.''' [[Transmission to immunization registries (MU2))|Transmission to immunization registries]] (<span style="color:white; background-color:green">Finalized - ZH Healthcare</span>)
:'''f3.''' [[Transmission to public health agencies – syndromic surveillance (MU2))|Transmission to public health agencies – syndromic surveillance]] (<span style="color:green;">owner is ZH Healthcare</span>)
:'''f3.''' [[Transmission to public health agencies – syndromic surveillance (MU2))|Transmission to public health agencies – syndromic surveillance]] (<span style="color:white;background-color:green">Finalized - ZH Healthcare. There are two solutions. ZH Healthcare solution is certified and in codebase. Ensoftek solution is in codebase but not yet certified.</span>)
:'''f5.''' [[Cancer case information (MU2))|Cancer case information]] (<span style="color:white;background-color:green">Optional and not needed for certification</span>) (<span style="color:green;">owner is ZH Healthcare</span>)
:'''f5.''' [[Cancer case information (MU2))|Cancer case information]] (<span style="color:white;background-color:green">Optional and not needed for certification</span>)
:'''f6.''' [[Transmission to cancer registries (MU2))|Transmission to cancer registries]] (<span style="color:white;background-color:green">Optional and not needed for certification</span>)
:'''f6.''' [[Transmission to cancer registries (MU2))|Transmission to cancer registries]] (<span style="color:white;background-color:green">Optional and not needed for certification</span>)


==Utilization (170.314(g))==
==Utilization (170.314(g))==
:'''g1.''' [[Automated numerator recording (MU2))|Automated numerator recording]] (<span style="color:green;">owner is OEMR</span>)
:'''g2.''' [[Automated measure calculation (MU2))|Automated measure calculation]] (<span style="color:white; background-color:green">Finalized - Ensoftek and ZH Healthcare and MI-Squared and Visolve and Brady Miller</span>)
:'''g2.''' [[Automated measure calculation (MU2))|Automated measure calculation]] (<span style="color:green;">owner is OEMR</span>)
:'''g3.''' [[Safety-enhanced design (MU2))|Safety-enhanced design]] (<span style="color:white; background-color:green">Finalized - Visolve and Brady Miller and Columbia University Health IT Certificate Program and MI-Squared and ZH Healthcare</span>)
:'''g3.''' [[Safety-enhanced design (MU2))|Safety-enhanced design]] (<span style="color:white; background-color:green">Finalized</span>)
:'''g4.''' [[Quality management system (MU2))|Quality management system]] (<span style="color:white; background-color:green">Finalized</span>)
:'''g4.''' [[Quality management system (MU2))|Quality management system]] (<span style="color:white; background-color:green">Finalized</span>)
<br>
<br>


=Features that Are Needed (ie. "Building Blocks")=
=Features that Are Needed (ie. "Building Blocks")=
:*Prescriptions/meds/allergies need to have a RxNorm association option. ('''Rod added support for this in 4.1.3''')
:*Prescriptions/meds/allergies need to have a RxNorm association option. ('''Rod added support for this in 4.2.0''')
:*Production and real incorporation of fully-featured CCD and CCD(a)s. ('''ZH is working on this''')
:*Production and real incorporation of fully-featured CCD and CCD(a)s. ('''ZH completed this and is in OpenEMR 4.2.1''')
:*Be able to connect to DIRECT. Here is home page of Direct: http://www.healthit.gov/policy-researchers-implementers/direct-project '''(EMR Direct provided a solution for this which has been committed into OpenEMR 4.1.2: [[Direct|Direct]]''')
:*Be able to connect to DIRECT. Here is home page of Direct: http://www.healthit.gov/policy-researchers-implementers/direct-project '''(EMR Direct provided a solution for this which was committed into OpenEMR 4.1.2: [[Direct|Direct]]''')
:*Medical problems need to have a SNOMED association option ('''Already supported since 4.1.1 version''')
:*Medical problems need to have a SNOMED association option ('''Already supported since 4.1.1 version''')
::*Need to support import of US SNOMED extension package in addition to the currently supported base international package (ie. need to be able to install/update both simultaneously). ('''This feature was committed to OpenEMR 4.1.2''')
::*Need to support import of US SNOMED extension package in addition to the currently supported base international package (ie. need to be able to install/update both simultaneously). ('''This feature was committed to OpenEMR 4.1.2''')


=Estimates=
=Estimates=
:*Here is a estimate by Visolve of the time to complete each certification criteria above. The estimate is approximately 80 work weeks of effort.
:*4/22/16 by Visolve on items a8, c1-3, and g2.
::*[[File:OpenEMR MUO Stage2 Estimation.pdf]]
::*Gap Analysis.
:::*[[Media:OpenEMR_MU2_Gap_Analysis.docx]]
::*Time estimate to complete and certify items.
:::*Development: 6 to 7 Engineering weeks
:::*Testing: 1 week
:::*Reasoning for estimate:
::::*CQM: Out of 9 measures, only 6 are available and those 6 have 400 errors. This requires analysis of the current code, code adjustment to fix the errors, and the incorporation of 3 additional measures into the report.
::::*Clinical Decision Support: Need to work on the Lab results rule. Need to validate the CCDA and Lab results incorporation. Given that it also deals with Newcrop, need to verify the diagnostic and therapeutic link for drug-drug, drug-allergy interaction, and need to confirm that it is currently available with Newcrop.
::::*Automated Measures Calculation: Based on Gap Analysis, still with 3 rules that need to be written, and with 2 rules failing. Moreover, have included the effort for validating 6 other rules in the estimate, which couldn't do in the gap analysis because they have dependencies on the Care Coordination module, Newcrop, offsite portal, and the lab module which will require resources to provide.
::*Cost to complete and certify items.
:::*Standard rate would be $7000
:::*Agreed to discounted rate of $3900, which was officially sponsored by OEMR organization on 4/27/2016.
::*Ongoing Updates
:::*5/12/2016
::::*Testing demo almost completed (Newcrop, Care Coordination Module, and CCDA are working; still working on the offsite Patient Portal).
::::*CQM 2011 Hypertension rule added to 2014 rules as a new rule.
::::*CQM coding for denominator exceptions was not yet completed, so working on coding that.
::::*CQM plan to add two new encounter categories (Behavioral Assessment and Preventative Care), map them to correct encounter types(and fix the original items to not map to these encounter type), and add a seq to the categories so can place these new categories near the bottom of selector.
::::*Because the SNOMED code type(for diagnostic codes) is not showing all necessary items when search, need to use the SNOMED-CT code type(all clinical codes) for Medical Problems. Will have this as a configuration change after install.
::::*Should have initial code to review in 1-2 weeks.
:::*8/8/2016
::::*Project was successfully completed.
<br>
:*1/10/13 estimate by Visolve of the time to complete all MU2 certification criteria above. The estimate was approximately 80 work weeks of effort.
::*[[Media:OpenEMR MUO Stage2 Estimation.pdf]]
 
=Acknowledgments=
:'''DEVELOPMENT WORK'''
:(NOTE THERE WERE A TOTAL OF 34 ITEMS THAT WERE WORKED ON)
:(BELOW PERCENTAGE IS THE TOTAL AMOUNT OF ITEMS THAT WAS WORKED ON BY THE COMPANY/DEVELOPER)
:*'''Ensoftek - 44%''' (15 completed items).
:*'''Visolve - 34%''' (14 completed items).
:*'''ZH Healthcare - 34%''' (14 completed items).
:*'''MI-Squared - 24%''' (8 completed items).
:*'''Brady Miller - 12%''' (4 completed items).
:*'''EMR Direct - 9%''' (3 completed items).
:*'''Jan Jajalla - 9%''' (3 completed items).
:*'''Sunset Systems - 9%''' (3 completed items).
:*'''Columbia University Health IT Certificate Program - 3%''' (1 completed item).
 
:'''HONORABLE MENTIONS FOR VOLUNTEERS'''
:*'''Jeff Guillory'''
:*'''Ray Magauran'''
:*'''John Tenny'''


=Notes=
=Notes=

Latest revision as of 10:12, 15 February 2017

Overview

This is the project page for the OpenEMR Certification Stage II Meaningful Use project. Modular Certification was obtained on December 24, 2014 (for OpenEMR 4.2.x which was released on 12/28/14). Complete Certification was obtained on February 13, 2017 (for OpenEMR 5.0.x which was released on 2/15/17). There are 45 Certification Criteria, which are organized into 7 different topics (Clinical, Care Coordination, Clinical Quality Measures, Privacy and Security, Patient Engagement, Public Health, and Utilization).
Here are some useful links:
  • Ongoing MU2 work by ZH Healthcare, which will be included in OpenEMR:


Fund Raising

This barometer will track the approximate funds available via the OEMR 501c3 that are dedicated to this goal
Not Funded Certification Test Funds Development Funds Expended Funds

Required to Pay for Testing and Certification

$1000 $5000 $10,000 $15,000 $20,000 $25,000

GOAL ACHIEVED! --Tony McCormick 22:27, 29 January 2014 (UTC)

Required to support development efforts and timely delivery

$2,500 $5,000 $10,000 $12,500 $15,000 $20,000 $25,000 $30,000 $35,000 $40,000 $45,000 $50,000 $55,000 $60,000 $65,000 $70,000 $75,000


Legend Description:
  • Not Funded - Unfunded Goal.
  • Certification Test Cost - Funds available to pay for Certification Testing
  • Development - Funds available for development work



Fund Drive for OpenEMR MU Certification

Please continue to help OpenEMR obtain Meaningful Use Certification!!


DONATE HERE



DONATE HERE


Completion Barometer

  • Modular Certification was obtained on December 24, 2014 (for OpenEMR 4.2.x which was released on 12/28/14).
  • Complete Certification was obtained on February 13, 2017 (for OpenEMR 5.0.x which was released on 2/15/17).
  • Was submitted for "Certification Body Review" on 12/14/2016. The "Certification Body" requested 5 items to be fixed on 1/18/2017, which were all passed by 2/8/17. The application was then resubmitted for "Certification Body Review" on 2/10/2017. Complete MU2 certification was officially certified on 2/13/2017!
  • This barometer is tracking the progress of the Stage 2 MU project. See below Certification Criteria section for criteria titles.
a1 a2 a3 a4 a5 a6 a7 a8 a9 a10 a11 a12 a13 a14 a15 b1 b2 b3 b4 b5 b7 c1 c2 c3 d1 d2 d3 d4 d5 d6 d7 d8 d9 e1 e2 e3 f1 f2 f3 g2 g3 g4


Legend Description:
  • Not Ready - Not ready for certification testing.
  • Ready - Ready for certification testing.
  • Failed Test - Issues found during certification testing.
  • Certification Pass - Passed certification, but not yet in official codebase.
  • Certification Pass - Passed certification and in official codebase.
  • Certification Body Review Issues - Issues requested by Certification Body to address.



Certification Criteria

Definitions for terms used in the below Criteria wiki pages:
  • Owner - This is the "current" person/group(s) that are working on this criteria and can be found in parenthesis next to the item.

Clinical (170.314(a))

a1. Computerized provider order entry (Finalized - Visolve)
a2. Drug-drug, drug-allergy interaction checks (Finalized - MI-Squared/NewCrop)
a3. Demographics (Finalized - Jan Jajalla and Visolve)
a4. Vital signs, body mass index, and growth charts (Finalized - Jan Jajalla)
a5. Problem list (Finalized - ZH Healthcare and Visolve)
a6. Medication list (Finalized)
a7. Medication allergy list (Finalized)
a8. Clinical decision support (Finalized - EnSoftek and Visolve and MI-Squared and Brady Miller)
a9. Electronic notes (Finalized - ZH Healthcare)
a10. Drug-formulary checks (Finalized - MI-Squared/ZH Healthcare Via NewCrop)
a11. Smoking status (Finalized - Brady Miller and Ensoftek)
a12. Image results Finalized - Ensoftek and Visolve)
a13. Family health history (Finalized - Ensoftek)
a14. Patient list creation (Finalized - Ensoftek and Visolve)
a15. Patient-specific education resources (Finalized - Sunset Systems)

Care Coordination (170.314(b))

b1. Transitions of care – receive, display, and incorporate transition of care/referral summaries (Finalized - ZH Healthcare and EMR Direct)
b2. Transitions of care – create and transmit transition of care/referral summaries (Finalized - ZH Healthcare and EMR Direct)
b3. Electronic prescribing (Finalized - MI-Squared/Ensoftek)
b4. Clinical information reconciliation (Finalized - ZH Healthcare)
b5. Incorporate lab tests and values/results (Finalized - Sunset Systems and MI-Squared)
b7. Data portability (Finalized - ZH Healthcare)

Clinical Quality Measures (170.314(c))

c1. Clinical quality measures - capture and export (Finalized - Ensoftek and Visolve)
c2. Clinical quality measures - import and calculate (Finalized - Ensoftek and Visolve)
c3. Clinical quality measures - electronic submission (Finalized - Ensoftek and Visolve)

Privacy and Security (170.314(d))

d1. Authentication, access control, and authorization (Finalized)
d2. Auditable events and tamper-resistance (Finalized - Ensoftek, MI-Squared, Sunset Systems, and Visolve)
d3. Audit report(s) (Finalized - Ensoftek and Visolve)
d4. Amendments (Finalized - Ensoftek)
d5. Automatic log-off (Finalized)
d6. Emergency access (Finalized)
d7. End-user device encryption (Finalized)
d8. Integrity (Finalized - Visolve)
d9. Accounting of disclosures (Finalized - Ensoftek)

Patient Engagement (170.314(e))

e1. View, download, and transmit to 3rd party (Finalized - ZH Healthcare and EMR Direct)
e2. Clinical summaries (Finalized - ZH Healthcare)
e3. Secure messaging (Finalized - ZH Healthcare)

Public Health (170.314(f))

f1. Immunization information (Finalized - Jan Jajalla)
f2. Transmission to immunization registries (Finalized - ZH Healthcare)
f3. Transmission to public health agencies – syndromic surveillance (Finalized - ZH Healthcare. There are two solutions. ZH Healthcare solution is certified and in codebase. Ensoftek solution is in codebase but not yet certified.)
f5. Cancer case information (Optional and not needed for certification)
f6. Transmission to cancer registries (Optional and not needed for certification)

Utilization (170.314(g))

g2. Automated measure calculation (Finalized - Ensoftek and ZH Healthcare and MI-Squared and Visolve and Brady Miller)
g3. Safety-enhanced design (Finalized - Visolve and Brady Miller and Columbia University Health IT Certificate Program and MI-Squared and ZH Healthcare)
g4. Quality management system (Finalized)


Features that Are Needed (ie. "Building Blocks")

  • Prescriptions/meds/allergies need to have a RxNorm association option. (Rod added support for this in 4.2.0)
  • Production and real incorporation of fully-featured CCD and CCD(a)s. (ZH completed this and is in OpenEMR 4.2.1)
  • Be able to connect to DIRECT. Here is home page of Direct: http://www.healthit.gov/policy-researchers-implementers/direct-project (EMR Direct provided a solution for this which was committed into OpenEMR 4.1.2: Direct)
  • Medical problems need to have a SNOMED association option (Already supported since 4.1.1 version)
  • Need to support import of US SNOMED extension package in addition to the currently supported base international package (ie. need to be able to install/update both simultaneously). (This feature was committed to OpenEMR 4.1.2)

Estimates

  • 4/22/16 by Visolve on items a8, c1-3, and g2.
  • Gap Analysis.
  • Time estimate to complete and certify items.
  • Development: 6 to 7 Engineering weeks
  • Testing: 1 week
  • Reasoning for estimate:
  • CQM: Out of 9 measures, only 6 are available and those 6 have 400 errors. This requires analysis of the current code, code adjustment to fix the errors, and the incorporation of 3 additional measures into the report.
  • Clinical Decision Support: Need to work on the Lab results rule. Need to validate the CCDA and Lab results incorporation. Given that it also deals with Newcrop, need to verify the diagnostic and therapeutic link for drug-drug, drug-allergy interaction, and need to confirm that it is currently available with Newcrop.
  • Automated Measures Calculation: Based on Gap Analysis, still with 3 rules that need to be written, and with 2 rules failing. Moreover, have included the effort for validating 6 other rules in the estimate, which couldn't do in the gap analysis because they have dependencies on the Care Coordination module, Newcrop, offsite portal, and the lab module which will require resources to provide.
  • Cost to complete and certify items.
  • Standard rate would be $7000
  • Agreed to discounted rate of $3900, which was officially sponsored by OEMR organization on 4/27/2016.
  • Ongoing Updates
  • 5/12/2016
  • Testing demo almost completed (Newcrop, Care Coordination Module, and CCDA are working; still working on the offsite Patient Portal).
  • CQM 2011 Hypertension rule added to 2014 rules as a new rule.
  • CQM coding for denominator exceptions was not yet completed, so working on coding that.
  • CQM plan to add two new encounter categories (Behavioral Assessment and Preventative Care), map them to correct encounter types(and fix the original items to not map to these encounter type), and add a seq to the categories so can place these new categories near the bottom of selector.
  • Because the SNOMED code type(for diagnostic codes) is not showing all necessary items when search, need to use the SNOMED-CT code type(all clinical codes) for Medical Problems. Will have this as a configuration change after install.
  • Should have initial code to review in 1-2 weeks.
  • 8/8/2016
  • Project was successfully completed.


  • 1/10/13 estimate by Visolve of the time to complete all MU2 certification criteria above. The estimate was approximately 80 work weeks of effort.

Acknowledgments

DEVELOPMENT WORK
(NOTE THERE WERE A TOTAL OF 34 ITEMS THAT WERE WORKED ON)
(BELOW PERCENTAGE IS THE TOTAL AMOUNT OF ITEMS THAT WAS WORKED ON BY THE COMPANY/DEVELOPER)
  • Ensoftek - 44% (15 completed items).
  • Visolve - 34% (14 completed items).
  • ZH Healthcare - 34% (14 completed items).
  • MI-Squared - 24% (8 completed items).
  • Brady Miller - 12% (4 completed items).
  • EMR Direct - 9% (3 completed items).
  • Jan Jajalla - 9% (3 completed items).
  • Sunset Systems - 9% (3 completed items).
  • Columbia University Health IT Certificate Program - 3% (1 completed item).
HONORABLE MENTIONS FOR VOLUNTEERS
  • Jeff Guillory
  • Ray Magauran
  • John Tenny

Notes

Some Analysis of Proposed Guidelines (Outdated)

Difference(s) from Stage 1
Improving quality, safety, efficiency, and reducing health disparities
Use computerized provider order entry (CPOE) for medication, laboratory and radiology orders directly entered by any licensed healthcare professional who can enter licensed healthcare professional who can enter orders into the medical record per State, local and professional guidelines to create the first record of the order.
More than 60 percent of medication, laboratory, and radiology orders created by the EP or authorized providers of the eligible hospital's or CAH's inpatient or emergency department (POS 21 or 23) during the EHR reporting period are recorded using CPOE.
  • Adds laboratory & radiology
  • Increased from 30% to 60%
  • Requirement is based on number of orders, not number of patients.
Generate and transmit permissible prescriptions electronically (eRx)
More than 65 percent of all permissible prescriptions written by the EP are compared to at least one drug formulary and transmitted electronically using Certified EHR Technology.
  • Increased from 40% to 65%.
  • Includes formulary check which formerly was part of menu set
Record the following demographics
  • Preferred language
  • Gender
  • Race
  • Ethnicity
  • Date of birth
More than 80 percent of all unique patients seen by the EP have demographics recorded as structured data
  • Increased from 50% to 80%.


Record and chart changes in vital signs:
  • Height/length
  • Weight
  • Blood pressure (age 3 and over)
  • Calculate and display BMI
  • Plot and display growth charts for patients 0-20 years, including BMI
More than 80 percent of all unique patients seen by the EP have blood pressure (for patients age 3 and over only) and height/length and weight (for all ages) recorded as structured data
  • Increased from 50% to 80%.
  • Changed from age 2 and over to age 3 and over.


Record smoking status for patients 13 years old or older More than 80% of all unique patients 13 years old or older seen by the have smoking status recorded as structured data
  • Increased from 50% to 80%.
Use clinical decision support to improve performance on high-priority health conditions
  1. Implement 5 clinical decision support interventions related to 5 or more clinical quality measures at a relevant point in patient care for the entire EHR reporting period.
  2. The EP has enabled and implemented the functionality for drug-drug and drug-allergy interaction checks for the entre EHR reporting period.
  • Increased from implementing one rule to five.
  • Must be related to five quality measures for entire reporting period.
  • Incorporates drug-drug/drug-allergy checks (formerly standalone requirement).


Incorporate clinical lab-test results into Certified EHR Technology as structured data
More than 55 percent of all clinical lab tests results ordered by the EP during the EHR reporting period whose results are either in a positive/negative or numerical format are incorporated in Certified EHR Technology as structured data
  • Formerly menu set item.
  • Increased from 40% to 55%.


Generate lists of patients by specific conditions to use for quality improvement, reduction of disparities, research, or outreach
Generate at least one report listing patients of the EP, eligible hospital or CAH with a specific condition.
  • Formerly menu set item.


Use clinically relevant information to identify patients who should receive reminders for preventive/follow-up care
More than 10 percent of all unique patients who have had an office visit with the EP within the 24 months prior to the beginning of the EHR reporting period were sent a reminder, per patient preference
  • Formerly menu set item.
  • Eliminated age parameters; changed to “unique patients who have had an office visit”
Engage patients and families in their health care
Provide patients the ability to view online, download, and transmit their health information within 4 business days of the information being available to the EP.
  1. More than 50 percent of all unique patients seen by the EP during the EHR reporting period are provided timely (within 4 business days after the information is available to the EP) online access to their health information subject to the EP's discretion to withhold certain information
  2. More than 10 percent of all unique patients seen by the EP during the EHR reporting period (or their authorized representatives) view, download , or transmit to a third party their health information
  • Formerly menu set item.
  • More specific
  • Increased from 10% to 50%
  • Added requirement for patients to “view, download or transmit” information.